New Jersey SR 26: Urges FDA to make naloxone available over the counter.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2018-01-16)

State: New Jersey · Session: 218 · Bill: SR 26

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey SR 26 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.